LakeShore Biopharma Co (LakeShore Biopharma Co) Short-Term Debt : $25.04 Mil (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Short-Term Debt?

LakeShore Biopharma Co's Short-Term Debt for the quarter that ended in Sep. 2023 was $25.04 Mil.

LakeShore Biopharma Co's quarterly Short-Term Debt increased from Sep. 2022 ($23.31 Mil) to Mar. 2023 ($28.12 Mil) but then declined from Mar. 2023 ($28.12 Mil) to Sep. 2023 ($25.04 Mil).

LakeShore Biopharma Co's annual Short-Term Debt increased from Mar. 2021 ($0.00 Mil) to Mar. 2022 ($17.61 Mil) and increased from Mar. 2022 ($17.61 Mil) to Mar. 2023 ($28.12 Mil).

LakeShore Biopharma Co Short-Term Debt Historical Data

The historical data trend for LakeShore Biopharma Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Short-Term Debt Chart

LakeShore Biopharma Co Annual Data

Trend

Mar21

Mar22

Mar23

Short-Term Debt

17.61

28.12

LakeShore Biopharma Co Semi-Annual Data
	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Short-Term Debt	Get a 7-Day Free Trial			-	17.61	23.31	28.12	25.04

LakeShore Biopharma Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

LakeShore Biopharma Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

H6Z:Germany

Address

38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629

Website

https://www.yishengbio.com

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.